Eric S. Hoffman
Corporate Officer/Principal chez FUSN PHAR
Profil
Eric S.
Hoffman is currently the Senior Vice President-Business Development at Fusion Pharmaceuticals, Inc. He previously worked as the Director-Corporate & Business Development at Biogen, Inc. from 2006 to 2011, and as the Vice President-Corporate & Business Development at Idenix Pharmaceuticals LLC from 2011 to 2014.
He also served as a Research Analyst at JPMorgan Securities LLC.
From 2014 to 2018, he was the Chief Business Officer at Genocea Biosciences, Inc. and later became the Chief Business Officer at Vicarius Pharma AG.
Dr. Hoffman received his undergraduate degree from Trinity University and his doctorate from Yale University.
Postes actifs de Eric S. Hoffman
| Sociétés | Poste | Début |
|---|---|---|
| FUSN PHAR | Corporate Officer/Principal | 21/09/2021 |
Anciens postes connus de Eric S. Hoffman
| Sociétés | Poste | Fin |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Corporate Officer/Principal | 01/09/2018 |
| IDENIX PHARMACEUTICALS INC | Investor Relations Contact | 22/05/2013 |
| BIOGEN INC. | Public Communications Contact | 01/03/2010 |
Vicarius Pharma AG
 Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Vicarius Pharma AG provides research and development services for pharmaceutical, biotech, and medical companies. The private company is based in Zurich, Switzerland. The Swiss company was founded by Hans-Peter Hasler. | Corporate Officer/Principal | - |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Analyst-Equity | - |
Formation de Eric S. Hoffman
| Trinity University | Undergraduate Degree |
| Yale University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| FUSN PHAR | Health Technology |
| Entreprise privées | 3 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Vicarius Pharma AG
Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Vicarius Pharma AG provides research and development services for pharmaceutical, biotech, and medical companies. The private company is based in Zurich, Switzerland. The Swiss company was founded by Hans-Peter Hasler. | Commercial Services |
